Data category	Information
Primary registry and trial identifying number	Clinicaltrials.gov: NCT05421273, registered Netherlands Trial Register NL9194, registered
Date of registration in primary registry	23 January 2021
Secondary identifying numbers	n/a
Source(s) of monetary or material support	Abbott Laboratories
Primary sponsor	Abbott Laboratories
Secondary sponsor(s)	N/A
Contact for public queries	MRM m.mons@maastrichtunversity.nl, JWK jkallewaard@rijnstate.nl
Contact for scientific queries	MRM m.mons@maastrichtunversity.nl, JWK jkallewaard@rijnstate.nl
Public title	N/A
Scientific title	Effects of Active Versus Passive Recharge Burst Spinal Cord Stimulation on Pain Experience in Persistent Spinal Pain Syndrome Type 2: A Multicenter Randomized Trial (BURST-RAP study)
Countries of recruitment	The Netherlands
Health condition(s) or problem(s) studied	Persistent Spinal Pain Syndrome Type 2
Intervention(s)	Passive recharge burst (Burst DRTM) spinal cord stimulation
	Active recharge burst spinal cord stimulation
Key inclusion and exclusion criteria	Ages eligible for study: ≥18 years Sexes eligible for study: both
	Inclusion criteria Subjects between 18 and 65 years of age At least moderate level of catastrophizing as measured with the Pain catastrophizing scale (PCS) of at least 20. History consistent with PSPS Type 2 of at least 6 months
	Exclusion criteria Subject is unable to operate the device Severe spinal column degeneration likely to cause technical problems with neuromodulation, to be assessed by the treating physician
Study type	Investigator initiated multicenter randomized clinical trial
	Allocation: Unblinded randomization
	Primary purpose: Pain Experience
Date of first enrolment	February 2022
Target sample size	94
Recruitment status	Recruiting
Primary outcome(s)	Change on the PCS scale
Key secondary outcomes	Change in low back and leg pain intenstity, PVAQ, HADS, EQ-5D, ODI, PGIC, analgesia intake and PainDETECT rates